Key result
High SCORE2-Diabetes is linked to ~14% higher odds of complex coronary disease.
Why the study?
Does the SCORE2-Diabetes risk score predict coronary disease complexity (assessed by SYNTAX score) and 1-year mortality in diabetic patients presenting with a first myocardial infarction?
Cohort (n=301)
No
Does the SCORE2-Diabetes risk score predict coronary disease complexity (assessed by SYNTAX score) and 1-year mortality in diabetic patients presenting with a first myocardial infarction?
In patients with diabetes presenting with a first myocardial infarction, a higher pre-event SCORE2-Diabetes score independently predicts greater coronary anatomical complexity, which in turn strongly drives 1-year mortality.
SCORE2-Diabetes ≥20% was associated with high coronary complexity in diabetic first MI; hypothesis-generating and requires prospective validation before clinical use.
Background Risk stratification in patients with diabetes mellitus (DM) remains challenging. Whether SCORE2-Diabetes, a primary prevention risk score, reflects coronary anatomy and clinical outcomes at first myocardial infarction (MI) is insufficiently explored. Purpose To evaluate the association between SCORE2-Diabetes, coronary disease complexity assessed by SYNTAX score, and 1-year mortality, in diabetic patients presenting with a first MI. Methods We retrospectively analyzed 301 consecutive patients with DM admitted for first MI (either STEMI or NSTEMI) in a tertiary university hospital. Patients with previously known atherosclerotic cardiovascular disease were excluded. SCORE2-Diabetes was calculated post-hoc, immediately prior to MI, and categorized as <10%, 10-20%, and >20%. Coronary complexity was assessed using the SYNTAX score (≤22, 23-32, ≥33). One-year all-cause mortality was recorded. Multivariable logistic regression was used to identify predictors of high coronary complexity and mortality. Results Higher SCORE2-Diabetes categories were associated with increasing coronary complexity. Patients with SCORE2-Diabetes >20% showed a significantly higher prevalence (48.6% vs 15.1%, p<0.001) of high SYNTAX scores (≥33) compared with lower-risk groups. By multivariable logistic regression, SCORE2-Diabetes ≥20% independently predicted high coronary complexity after adjustment for sex, diabetes duration, and HbA1c at admission (OR 1.14, 95% CI 1.06–1.24; p = 0.009). At 1 year, all-cause mortality was 18.7%. Mortality increased stepwise with coronary complexity; Kaplan–Meier survival analysis (Figure 1) demonstrated a markedly reduced survival probability in the high SYNTAX group score > 33 compared with < 33 (63.4% vs 89.4% at 1 year; log-rank p<0.001). Cox proportional hazards analysis showed that SYNTAX >33 was associated with a 3.4-fold increased risk of all-cause mortality (HR ≈3.4). By multivariable analysis, coronary complexity assessed by SYNTAX score remained an independent predictor of 1-year mortality, together with reduced left ventricular ejection fraction <40% and incomplete revascularization (all p<0.05). Conclusion In diabetic patients presenting with a first MI, SCORE2-Diabetes identifies individuals with more complex coronary anatomy. Coronary complexity, in turn, drives 1-year mortality. Risk assessment in diabetic patients is essential, since it predicts both coronary anatomy and prognosis of first MI.
No takes yet. Share an insight, caveat, or question.
Spataru et al. (2026) conducted a cohort in Diabetes mellitus with first myocardial infarction (STEMI or NSTEMI) (n=301). SCORE2-Diabetes >20% (and ≥20%) vs. Lower SCORE2-Diabetes risk groups (<10% and 10-20%) was evaluated on High coronary complexity (SYNTAX score ≥33) (OR 1.14, 95% CI 1.06-1.24, p=0.009). SCORE2-Diabetes ≥20% independently predicted high coronary complexity (SYNTAX ≥33; 48.6% vs 15.1%; adjusted OR 1.14, 95% CI 1.06–1.24; P=0.009), which in turn predicted 1-year mortality (HR ≈3.4).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: